How to get employees with back pain back to work faster
About 80% of adults will experience low back pain at some point in their lifetimes, making it the most common cause of job-related disability and a major contributor to days off work. When surgery is involved, the ailment can be costly to treat. As both a cost- and medically-effective solution, health care payers have made integrating chiropractic care into treatment protocols a priority. Back pain is the second-most-common reason a person visits a doctor, according to the Cleveland Clinic. Dr.… (Source: Health Care:Biotechnology headlines)
Source: Health Care:Biotechnology headlines - February 5, 2020 Category: Biotechnology Authors: Laura Newpoff Source Type: news

An Interdisciplinary Pain Program for Chronic Low Back Pain An Interdisciplinary Pain Program for Chronic Low Back Pain
Is an interdisciplinary treatment approach an effective means of symptom improvement in chronic low back pain? How does it compare with physical therapy?Spine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2020 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Many Patients Receive Guideline-Nonconcordant Care for Low Back Pain
THURSDAY, Jan. 30, 2020 -- Many patients who develop new low back pain (LBP) receive advanced imaging and opioids without having been prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) or physical therapy (PT), according to a study published... (Source: - Pharma News)
Source: - Pharma News - January 30, 2020 Category: Pharmaceuticals Source Type: news

Medicare Opts to Cover Acupuncture for Pain Amid Opioid Crisis Medicare Opts to Cover Acupuncture for Pain Amid Opioid Crisis
CMS reverses its past stance on acupuncture and outlines terms for Medicare coverage of the treatment for low back pain.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2020 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Medicare to Cover Some Acupuncture in AAFP Advocacy Win
CMS announced new Medicare coverage for acupuncture for chronic low back pain, cementing a proposed policy that the Academy endorsed last summer. (Source: AAFP News)
Source: AAFP News - January 28, 2020 Category: Primary Care Source Type: news

Low-Back Pain and Complementary Health Approaches: What You Need To Know
What ’s the Bottom Line?What do we know about the effectiveness of complementary health approaches for low-back  pain? (Source: NCCAM Featured Content)
Source: NCCAM Featured Content - January 28, 2020 Category: Complementary Medicine Authors: NCCIH Source Type: news

Medicare Will Now Pay For Acupuncture In Part Due To Opioid Abuse
The Centers for Medicare& Medicaid Services (CMS) has announced that Medicare will now cover acupuncture for patients with chronic low back pain in part because of the widespread abuse of opioids in America. (Source: Healthcare News)
Source: Healthcare News - January 24, 2020 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news

CT, MRI for lower back pain still prevalent in ED
The rate of CT and MRI scans for back pain remained steady from 2001 to 2016...Read more on AuntMinnie.comRelated Reading: IMV: MR providers work harder as procedure volume grows Are too many patients getting MRI scans for back pain? Less jargon makes MRI reports easier to read DeepSpine AI enhances grading of lumbar spinal stenosis Johns Hopkins tackles problem of unnecessary scans (Source: Headlines)
Source: Headlines - January 24, 2020 Category: Radiology Source Type: news

More autonomy at work reduces the risk of low back pain
(Technische Universit ä t Dresden) A team of psychologists from Technische Universit ä t Dresden, in cooperation with experts from health sciences and the Federal Institute for Occupational Safety and Health, has carried out a meta-analysis to identify psychosocial work factors that pose a risk for the development of chronic low back pain (CLBP). Their study clearly indicates that not only physical but also psychological and social factors exert considerable influence on the development of the disease. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 23, 2020 Category: International Medicine & Public Health Source Type: news

Myths may worsen low back pain and promote ineffective treatments
(Reuters Health) - Common myths about low back pain could lead to more pain, ineffective care and unwarranted anxiety, researchers say. (Source: Reuters: Health)
Source: Reuters: Health - January 16, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Lower back pain may be caused by cartilage turning into bone that looks like SWISS CHEESE
Cartilage should be soft and firm, protecting the spine vertebrae. But a study on mice at Johns Hopkins University School of Medicine, Baltimore, found it had hardened and looked like Swiss cheese. (Source: the Mail online | Health)
Source: the Mail online | Health - January 15, 2020 Category: Consumer Health News Source Type: news

Its opioid dissed by FDA advisors, S.F. drugmaker abandons program
A rejection of its experimental pain drug Tuesday forced Nektar Therapeutics Inc. to dump the program. In a rare indisputable rejection, two Food and Drug Administration advisory committees voted 27-0 to recommend that the FDA not approve the San Francisco company's oxycodegol, a slow-acting opioid aimed at chronic lower back pain. The FDA isn't required to live by the advisory committees' recomme ndation, but six hours later Nektar (NASDAQ: NKTR) said it would withdraw its approval request and… (Source: Health Care:Pharmaceuticals headlines)
Source: Health Care:Pharmaceuticals headlines - January 15, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Nektar withdraws application for opioid painkiller after FDA panel's vote
Nektar Therapeutics said on Tuesday it was withdrawing the application for its opioid painkiller for adults with chronic low back pain, after a U.S. Food and Drug Administration (FDA) panel unanimously voted against the drug's approval. (Source: Reuters: Health)
Source: Reuters: Health - January 15, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. FDA panel votes against approval of Nektar's opioid painkiller
Independent advisers to the U.S. Food and Drug Administration on Tuesday unanimously voted against Nektar Therapeutics' opioid painkiller for adults with chronic low back pain, sending the drug developer's shares down 12% in extended trading. (Source: Reuters: Health)
Source: Reuters: Health - January 14, 2020 Category: Consumer Health News Tags: healthNews Source Type: news